PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

The US Food and Drug Administration (FDA) has granted accelerated approval of PTC Therapeutics’ gene therapy for the ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene ... coats in ...

PPL will increase its 'price to compare' rates this December, the utility company announced recently. PPL Electric delivers ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the New ...

There is some positive news for Guardiola with Nathan Ake’s return to fitness, but the defender has to settle for a place on the bench here. City remain without long-term absentees Rodri and ...

PTC CEO Neil Barua emphasises the importance of India in the global market despite current setbacks in the automotive industry. Barua highlights PTC's focus on software-defined vehicles and its ...

The US Citizenship and Immigration Services have released the US visa bulletin for November 2024. The official document prepares aspiring green card applicants for what's to come ahead.